COPENHAGEN, Denmark – August 21, 2025. Novonesis delivered 9% organic sales growth in H1 and full-year outlook range narrowed to 6-8%. En cliquant sur ce lien, vous acceptez l'utilisation de cookies ...

A presentation of the results of the Denali trial is available on our website, www.nicox.com.

Nicox SA (Euronext Growth Paris : FR0013018124, ALCOX, éligible PEA-PME), une société internationale spécialisée en ophtalmologie, annonce aujourd’hui que l’administration quotidienne en une seule dos ...

Following a successful execution in the first half of the year, and GN’s company-wide agility, the financial guidance for 2025 is confirmed. The organic revenue growth guidance of -3% to +3% ...

2025 outlook: Organic sales growth range narrowed to 6-8% (previously 5-8%), and 7-9% excluding the exit from certain countries (previously 6-9%). Adjusted EBITDA margin is maintained at 37-38%, ...

Cantor is acting as sole book-running manager for the offering.

An investor webcast and conference call will be held at 9.30am AEST on Thursday 21 August 2025 (7.30pm EDT Wednesday 20 August 2025). Participants can register for the webcast by clicking here: or ...

T1DM is an autoimmune disorder characterized by the destruction of beta cells, resulting in an absolute deficiency of insulin ...

MyndMed™’s formula, developed by BioAdaptives’ research team, incorporates a precise blend of botanical extracts, amino acids, and neuro-support nutrients designed to support neurotransmitter balance, ...

King Faisal Specialist Hospital and Research Centre (KFSHRC) delivered 293,381 virtual clinic visits in 2024, a 58.2% increase from the previous year. The growth highlights how telehealth has become ...

MediWound Ltd. (Nasdaq: MDWD) is a global biotechnology company focused on developing and commercializing enzymatic therapies for non-surgical tissue repair. The company’s FDA-approved biologic, ...

Inspire is scheduled to present at 11:00 a.m. Eastern Time. The presentation will be accessible via a live webcast here. A webcast replay of the presentation will be available for two weeks following ...